Simon, J K, Staerke, N B, Hemming-Harlo, M, Layle, S, Dagan, R, Shekar, T, Pedley, A, Jumes, P, Tamms, G, Sterling, T, Musey, L, Buchwald, U K & for the V114-020 PNEU-TRUE study group 2022, ' Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years : A randomized phase 3 trial (PNEU-TRUE) ', Vaccine, vol. 40, no. 9, pp. 1342-1351 . https://doi.org/10.1016/j.vaccine.2021.12.067